Today’s world is all about moving forward by efficiently scaling back. Technology has changed the way business functions by providing the tools to save time and expense. At POZEN we fully recognize the value in this; as well as other ways to make our business model provide higher returns on our investments.  Our focus on transforming medicines, patient lives, and engaging with all our customers in new and different ways, will result in transforming our value to investors. In this case, less is more. Much more.

Investors

POZEN Inc., headquartered in Chapel Hill, NC, is a pharmaceutical company committed to transforming medicine that transforms lives. Since its founding in 1996, POZEN has successfully created novel pharmacologic agents primarily for pain and pain-related conditions by combining existing drug therapies that result in superior patient outcomes. Moving forward, POZEN is poised to become a model 21st century pharmaceutical company dedicated to ensuring that they produce cost-effective, evidence-based medicines; take a fresh approach to sales, marketing and medical education; and deliver high-quality, affordable pharmaceuticals to their customers.

Wells Fargo 2011 Global Life Sciences Conference June 22, 2011

Jefferies 2011 Global Life Sciences Conference June 6, 2011

10th Annual Needham & Co. Healthcare Conference April 5, 2011

POZEN Inc. Rings The NASDAQ Stock Market Closing Bell December 8, 2009

  • Webcast – Replay
    Q2 2011 Pozen Inc Earnings Conference Call
    July 28, 2011 at 11:00 a.m. ET
  • Webcast – Replay
    Pozen Inc at Wells Fargo Securities Healthcare Conference
    June 22, 2011 at 9:00 a.m. ET
  • Webcast – Replay
    Pozen Inc at Jefferies & Co. Global Life Sciences Conference
    June 06, 2011 at 11:00 a.m. ET

Recent News

August 16, 2011 - POZEN Welcomes Clint Burrus as Vice President, Customer Development
August 08, 2011 - Pozen Patents Upheld in Treximet Patent Litigation
July 28, 2011 - POZEN Reports Second Quarter 2011 Results